Location History:
- Malmö, SE (2013)
- Hørsholm, DE (2018)
Company Filing History:
Years Active: 2013-2018
Title: The Innovations of Inventor Marie Lindholm
Introduction: Marie Lindholm is a notable inventor based in Hørsholm, Denmark, recognized for her contributions to medical science through her innovative patents. With a total of two patents to her name, Lindholm's work primarily focuses on targeting Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), which has significant implications in treating hypercholesterolemia and related medical conditions.
Latest Patents: Lindholm's latest patents showcase her expertise in developing oligonucleotide conjugates and antisense oligomers that target PCSK9 mRNA within cells. Her first patent, addressing oligomeric compounds and conjugates, describes how these innovations lead to a reduction in PCSK9 expression. This reduction is vital for the management of various medical disorders, particularly hypercholesterolemia. Similarly, her second patent revolves around oligomer compounds that also target PCSK9 mRNA, reiterating her commitment to advancing medical treatment options.
Career Highlights: Throughout her career, Marie Lindholm has made significant strides in the field of biomedicine by working with esteemed companies such as Santaris Pharma A/S and Roche Innovation Center Copenhagen A/S. Her experiences in these organizations have provided her with a robust foundation in research and development, enabling her to innovate and bring her ideas to fruition.
Collaborations: In her journey as an inventor, Marie Lindholm has collaborated with respected professionals in the field, including Niels Fisker Nielsen and Ellen Marie Straarup. These partnerships have contributed to her ability to develop groundbreaking ideas and patents that hold promise for the future of medical treatment.
Conclusion: Marie Lindholm stands out as a distinguished inventor whose innovations in targeting PCSK9 represent significant advancements in medical science. Her work holds the potential to transform the landscape of treatment for hypercholesterolemia and related disorders, marking her as an influential figure in the realm of medical research and patent development.